Streetbeat News

Stock Prices

KKR

KKR & Co (NYSE:KKR) is analyzed against its Capital Markets industry peers, showing potential undervaluation based on its PE ratio but overvaluation on PB and PS ratios. With a higher ROE, EBITDA, gross profit, and revenue growth compared to industry averages, KKR demonstrates strong operational efficiency and growth prospects. The article also compares financial metrics like debt-to-equity ratio, positioning KKR in the middle among its top 4 peers.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 4:00 pm

NEM

Newmont (NYSE:NEM) has seen a surge in options activity, with 58% of traders bullish and 42% bearish. Notable trades include both puts and calls, with a price target range from $25.0 to $55.0. Newmont, the world's largest gold miner, recently acquired Newcrest, boosting its production and reserves. Currently, NEM's stock is down by -2.14% at $30.61, with analysts from BMO Capital and RBC Capital giving price targets of $56 and $40, respectively.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 4:00 pm

BLDR

Builders FirstSource (NYSE:BLDR) has significantly outperformed the market with an annualized return of 68.25% over the past 5 years, turning a $1000 investment into $13,579.33. The company now has a market capitalization of $23.29 billion.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 4:00 pm

REGN

Over the past 20 years, Regeneron Pharmaceuticals (NASDAQ:REGN) has produced an average annual return of 23.18%, outperforming the market by 15.52%. A $100 investment in REGN 20 years ago would be worth $6,532.07 today. The company's current market capitalization stands at $107.54 billion.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 4:00 pm

EGLE

Eagle Bulk Shipping (NYSE:EGLE) has been evaluated by 4 analysts over the last three months, with all maintaining an indifferent stance. The average 12-month price target for EGLE has been adjusted to $53.55, down from $63.00, indicating a 15.0% decrease. The company's financial performance shows challenges in revenue growth, profitability, and debt management, with a notable revenue decline of -55.42% over the past 3 months and below-average net margin and ROE.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 4:00 pm

ELAN

Elanco Animal Health Inc (NYSE:ELAN) reported Q4 2023 revenue of $1.035 billion, a 5% increase, surpassing consensus estimates. Adjusted EPS was $0.08, missing expectations and down 59% Y/Y. Pet Health revenue declined by 1%, while Farm Animal revenue grew by 10%. The company announced a restructuring impacting 420 personnel, aiming for annualized savings. FY 2024 sales are forecasted between $4.45 billion and $4.54 billion, with adjusted EPS of $0.87-$0.95. ELAN shares dropped 0.58% to $16.28.

Portfolio Pulse from Vandana Singh

February 26, 2024 | 3:54 pm

NVS

RHHBY

Roche Holdings AG and Novartis AG announced positive results from the Phase 3 OUtMATCH study of Xolair for treating multiple food allergies, showing increased tolerance to common allergens. The FDA approved Xolair's expanded use based on this data. NVS shares slightly declined.

Portfolio Pulse from Vandana Singh

February 26, 2024 | 3:52 pm

DELL

Dell Technologies announced the introduction of a new portfolio of commercial AI laptops and mobile workstations, leading to a rise in its shares.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 3:51 pm

NVDA

Nvidia (NASDAQ:NVDA) reported strong results, overshadowing hawkish Fed speeches and FOMC meeting minutes, leading to a rise in Treasury yields. The article discusses the impact of delayed Fed rate cuts, increased Treasury issuance, and the implications for various sectors, including technology, financials, and real estate. It highlights the importance of the Fed's policy on the broader market and specific sectors, with a focus on the potential underperformance of financials and rate-sensitive sectors.

Portfolio Pulse from Barry Knapp

February 26, 2024 | 3:50 pm

EWD

SPY

VGK

The Hungarian Parliament has officially approved Sweden's accession to NATO, marking a significant step in Sweden's journey to join the North Atlantic Treaty Organization. This development could have implications for defense-related stocks and ETFs, particularly those with exposure to European markets or the defense sector.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 3:47 pm